Flow cytometric detection of vancomycin-resistant Enterococcus faecium in urine using fluorescently labelled enterocin K1.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
06 07 2023
Historique:
received: 22 12 2022
accepted: 03 07 2023
medline: 10 7 2023
pubmed: 7 7 2023
entrez: 6 7 2023
Statut: epublish

Résumé

A urinary tract infection (UTI) occurs when bacteria enter and multiply in the urinary system. The infection is most often caused by enteric bacteria that normally live in the gut, which include Enterococcus faecium. Without antibiotic treatment, UTIs can progress to life-threatening septic shock. Early diagnosis and identification of the pathogen will reduce antibiotic use and improve patient outcomes. In this work, we develop and optimize a cost-effective and rapid (< 40 min) method for detecting E. faecium in urine. The method uses a fluorescently labelled bacteriocin enterocin K1 (FITC-EntK1) that binds specifically to E. faecium and is then detected using a conventional flow cytometer. Using this detection assay, urine containing E. faecium was identified by an increase in the fluorescent signals by 25-73-fold (median fluorescence intensity) compared to control samples containing Escherichia coli or Staphylococcus aureus. The method presented in this work is a proof of concept showing the potential of bacteriocins to act as specific probes for the detection of specific bacteria, such as pathogens, in biological samples.

Identifiants

pubmed: 37414859
doi: 10.1038/s41598-023-38114-9
pii: 10.1038/s41598-023-38114-9
pmc: PMC10325980
doi:

Substances chimiques

Vancomycin 6Q205EH1VU
enterocin 59678-46-5
Anti-Bacterial Agents 0
Bacteriocins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10930

Informations de copyright

© 2023. The Author(s).

Références

Appl Environ Microbiol. 2016 Aug 15;82(17):5216-24
pubmed: 27316965
Ann Epidemiol. 2000 Nov;10(8):509-15
pubmed: 11118930
Clin Microbiol Infect. 2016 Jun;22(6):561.e1-6
pubmed: 26899829
Front Microbiol. 2018 Sep 04;9:2085
pubmed: 30233551
Sci Rep. 2021 Jul 6;11(1):13909
pubmed: 34230527
Am J Obstet Gynecol. 2018 Jul;219(1):40-51
pubmed: 29305250
PLoS One. 2019 Aug 7;14(8):e0220307
pubmed: 31390352
Nat Rev Urol. 2010 Dec;7(12):653-60
pubmed: 21139641
Urol Clin North Am. 2015 Nov;42(4):547-60
pubmed: 26475951
J Biol Chem. 2014 Aug 22;289(34):23838-45
pubmed: 24993828
Pediatrics. 2018 Feb;141(2):
pubmed: 29339563
Nat Protoc. 2006;1(2):1001-5
pubmed: 17406337
Biochimie. 2002 May-Jun;84(5-6):499-510
pubmed: 12423794
Clin Infect Dis. 2004 Apr 15;38(8):1150-8
pubmed: 15095222
J Biol Chem. 2003 Sep 5;278(36):34291-8
pubmed: 12801935
Nat Commun. 2013;4:2584
pubmed: 24129412
J Bacteriol. 2000 Dec;182(23):6806-14
pubmed: 11073927
Int J Microbiol. 2021 Apr 21;2021:5541706
pubmed: 34035817
Infect Dis Clin North Am. 2014 Mar;28(1):75-89
pubmed: 24484576
Arch Microbiol. 1997 Feb-Mar;167(2-3):67-77
pubmed: 9133328
J Clin Microbiol. 2016 Apr;54(4):988-93
pubmed: 26818668
Front Microbiol. 2017 May 03;8:774
pubmed: 28515717
Ther Adv Urol. 2019 May 02;11:1756287219832172
pubmed: 31105774
J Clin Microbiol. 2010 Jun;48(6):2110-5
pubmed: 20392910
J Pediatr. 2017 Dec;191:259-261.e1
pubmed: 28967387
Front Microbiol. 2015 Aug 05;6:791
pubmed: 26300860
Microbiol Spectr. 2022 Aug 31;10(4):e0095422
pubmed: 35730941
Annu Rev Microbiol. 2002;56:117-37
pubmed: 12142491
Clin Chim Acta. 2010 Aug 5;411(15-16):1137-42
pubmed: 20359474
Dtsch Arztebl Int. 2010 May;107(21):361-7
pubmed: 20539810
Lancet Infect Dis. 2003 Apr;3(4):223-9
pubmed: 12679265
BMJ. 2019 Feb 27;364:l525
pubmed: 30814048
Mol Microbiol. 2014 Jun;92(6):1159-63
pubmed: 24811684
Appl Environ Microbiol. 1998 Feb;64(2):439-45
pubmed: 9464377
Med Decis Making. 2011 May-Jun;31(3):405-11
pubmed: 21191120
Crit Rev Microbiol. 2022 Jun 22;:1-20
pubmed: 35731254
Int J Food Microbiol. 2001 Aug 15;68(1-2):93-104
pubmed: 11545225
Biosens Bioelectron. 2008 Jun 15;23(11):1721-7
pubmed: 18378438
Nat Prod Rep. 2007 Aug;24(4):708-34
pubmed: 17653356
Antibiotics (Basel). 2014 May 05;3(2):174-92
pubmed: 27025743
Oxid Med Cell Longev. 2021 Apr 10;2021:5518825
pubmed: 33936381
Microbiology (Reading). 2002 Jul;148(Pt 7):2019-2027
pubmed: 12101290
Appl Environ Microbiol. 1997 Dec;63(12):4770-7
pubmed: 9406395
Front Microbiol. 2020 Nov 09;11:586433
pubmed: 33240239
J Biol Chem. 2022 Nov;298(11):102593
pubmed: 36244452
Curr Urol Rep. 2022 Sep;23(9):165-174
pubmed: 35877059
FEMS Microbiol Rev. 2021 Jan 8;45(1):
pubmed: 32876664
Appl Environ Microbiol. 2016 Aug 15;82(17):5364-74
pubmed: 27342562
Sci Rep. 2019 Oct 28;9(1):15422
pubmed: 31659220
BMJ Open. 2020 Jun 3;10(6):e033424
pubmed: 32499256
J Bacteriol. 2010 Nov;192(22):5906-13
pubmed: 20870773
Chest. 2009 Nov;136(5):1237-1248
pubmed: 19696123

Auteurs

Thomas F Oftedal (TF)

Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway. thof@nmbu.no.

Dzung B Diep (DB)

Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH